News
Public · Published
Henry Schein Q3 sales slightly miss, raises 2026 profit outlook
Henry Schein reported third-quarter sales rose 4%, slightly missing analyst expectations. Adjusted earnings per share, or profit allocated to each share, rose 13% and beat expectations. The company raised its 2026 outlook for adjusted profit measures and maintained its forecast for total sales growth.
Published:
Updated:
What happened
Henry Schein reported third-quarter sales rose 4%, slightly missing analyst expectations. Adjusted earnings per share, or profit allocated to each share, rose 13% and beat expectations. The company raised its 2026 outlook for adjusted profit measures and maintained its forecast for total sales growth.
Confirmed
Global impact / market context
Higher profit guidance despite a small sales shortfall suggests earnings can improve through factors beyond overall sales growth. The company cited U.S. dental merchandise volume and market-share gains, while tariff refunds also benefited the quarter; these factors may influence how investors assess the durability of future profit growth.
Analyst inference
Henry Schein kept its 2026 sales-growth outlook at 4.5%–5.5% but lifted its adjusted profit-per-share range to $5.50–$5.56 and expects adjusted EBITDA growth in the high single digits. EBITDA is earnings before interest, taxes, depreciation and amortization, a measure of operating performance.
Confirmed
What to watch
- Future results can show whether U.S. dental merchandise volume and market-share gains continue to support sales and profit, rather than reflecting a one-quarter improvement. Analyst inference
- The company raised its 2026 non-GAAP diluted earnings-per-share guidance to $5.50–$5.56; non-GAAP excludes certain items from reported profit. Confirmed
- Check whether the expected high-single-digit adjusted EBITDA growth is achieved, and whether tariff refunds recur or contributed only to this quarter’s results. Analyst inference
Evidence
- Original source link unavailable